| INFARMED [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | Neurologico
> Sclerosi multipla | Partenariato normativo
> Collaborazione con gli organismi di regolamentazione | 1000 | National | Regularly | 115015053859 |
| We are partners in the Projeto Incluir [Inclusion Project] led by Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | Cancro
> Cancro: seno | Partenariato normativo
> Collaborazione con gli organismi di regolamentazione | 1000 | Regional | Regularly | 115017018417 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | Perdita dell'udito
> Perdita dell'udito | Partenariato normativo
> Collaborazione con gli organismi di regolamentazione | 100 | National | No | 115029020137 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | Cerebrovascolare
> Tratto | Partenariato normativo
> Collaborazione con gli organismi di regolamentazione | 5000 | National | Regularly | 115032426383 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Difesa del paziente
> Difesa del paziente | Partenariato normativo
> Collaborazione con gli organismi di regolamentazione | 5000 | National | Rarely | 115033491291 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | Salute mentale
> Salute mentale: la maggior parte delle condizioni | Partenariato normativo
> Collaborazione con gli organismi di regolamentazione | 10.000 | National | Regularly | 115056273634 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Difesa del paziente
> Difesa del paziente | Partenariato normativo
> Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 5000 | National | Rarely | 115033491291 |
| We occasionally receive a form through which we are invited to submit written contributions to HTA [Avaliação de Tecnologias de Saúde – Health Technology Assessment] processes. | Reumatico
> Malattie reumatiche: la maggior parte dei tipi | Partenariato normativo
> Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 100 | National | Sometimes | 115060632863 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | Neurologico
> Sclerosi multipla | Partenariato normativo
> Partecipare alle valutazioni di Health Technology Assessment (HTA) e alle revisioni dei rimborsi | 5000 | National | Regularly | 115060898897 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Difesa del paziente
> Difesa del paziente | Partenariato normativo
> Contribuire alle presentazioni per l'Autorizzazione all'Immissione in Commercio | 5000 | National | Rarely | 115033491291 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | Perdita dell'udito
> Perdita dell'udito | Partenariato normativo
> Partecipare/facilitare riunioni con responsabili politici/regolatori | 100 | National | No | 115029020137 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Difesa del paziente
> Difesa del paziente | Partenariato normativo
> Partecipare/facilitare riunioni con responsabili politici/regolatori | 5000 | National | Rarely | 115033491291 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | Neurologico
> Sclerosi multipla | Partenariato normativo
> Partecipare/facilitare riunioni con responsabili politici/regolatori | 5000 | National | Regularly | 115060898897 |
| Negotiation with the government or with parliamentary groups. | Salute generale
> Obesità | Influenzare le politiche e la legislazione
> Influenzare le politiche sanitarie e la legislazione | 1000 | National | Regularly | 115006675660 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratorio
> Asma | Influenzare le politiche e la legislazione
> Partecipa alle audizioni pubbliche e alle consultazioni | Do not know | National | Sometimes | 115032964525 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratorio
> Asma | Influenzare le politiche e la legislazione
> Partecipa alle audizioni pubbliche e alle consultazioni | Do not know | National | Sometimes | 115032964525 |
| 2023: meeting with the Parliamentary Health Group at the AR [Assembleia da República – Assembly of the Republic]. | Cardiovascolare
> Condizioni cardiovascolari e cardiache | Influenzare le politiche e la legislazione
> Partecipa alle audizioni pubbliche e alle consultazioni | 1000 | National | Sometimes | 115054128784 |
| Negotiation with the government or with parliamentary groups. | Salute generale
> Obesità | Influenzare le politiche e la legislazione
> Mobilitare parlamentari e leader politici | 1000 | National | Regularly | 115006675660 |
| Each year, we submit our advocacy document to the parliamentary groups. | Disabilità
> Disabilità: la maggior parte dei tipi | Influenzare le politiche e la legislazione
> Mobilitare parlamentari e leader politici | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Through the Parliamentary Health Group. | Cardiovascolare
> Condizioni cardiovascolari e cardiache | Influenzare le politiche e la legislazione
> Mobilitare parlamentari e leader politici | 100 | National | Regularly | 115033109950 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | Disabilità
> Disabilità: la maggior parte dei tipi | Advocacy per prezzi e accessibilità economica
> Sostenere prezzi equi dei farmaci | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | Disabilità
> Disabilità: la maggior parte dei tipi | Advocacy per prezzi e accessibilità economica
> Affrontare le barriere di costo per le persone a basso reddito e vulnerabili | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Active participation in discussions on access to PAP [Programas de Acesso Precoce – Early Access Programmes] and in the centralised funding of medicines intended for rare diseases. | Neuromuscolare
> Malattie neuromuscolari: la maggior parte dei tipi | Miglioramento dei percorsi di accesso
> Miglioramento dell'accesso alle terapie rare/ultra-rare | 1000 | National | Regularly | 115022855373 |
| Questionnaire for the collection of contributions from patient associations in the context of Health Technology Assessment [in Portugal]. | Gastrointestinale
> Gastrointestinale: altro | Contributo del paziente basato sull'evidenza
> Condurre sondaggi/ricerche per generare dati | 1000 | National | Sometimes | 114997613546 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratorio
> Asma | Contributo del paziente basato sull'evidenza
> Condurre sondaggi/ricerche per generare dati | Do not know | National | Sometimes | 115032964525 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | Cerebrovascolare
> Tratto | Governance istituzionale
> Garantire la rappresentanza negli organi consultivi governativi | 5000 | National | Regularly | 115032426383 |
| Projeto Incluir [The project establishes a formal mechanism for patient rights and civic participation in Portugal. It allows patients and their advocacy organizations to have an active voice in Health Technology Assessment (HTA), Medicine Shortages & Safety and Policy Representation: Acting as a bridge between policymakers and citizens, ensuring that healthcare decisions account for patient values and experiences.] | Difesa del paziente
> Diritti del paziente | Governance istituzionale
> Garantire la rappresentanza negli organi consultivi governativi | 5000 | National | Regularly | 115042989304 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | Salute mentale
> Salute mentale: la maggior parte delle condizioni | Governance istituzionale
> Garantire la rappresentanza negli organi consultivi governativi | 10.000 | National | Regularly | 115056273634 |
| Through the Parliamentary Health Group. | Cardiovascolare
> Condizioni cardiovascolari e cardiache | Governance istituzionale
> Lavorare efficacemente all'interno di reti multi-stakeholder | 100 | National | Regularly | 115033109950 |
interazioni
azioni e advocacy
13 menzioni
